• Tackling the Logistical Challenges of DCTS: Joined Up Services and Owning the Process

    Clinical Research News | When hybrid and decentralized clinical trials rely on a patchwork of different suppliers, vendors, and couriers, logistics become a substantial administrative burden for sponsors and sites alike. That’s why an integrated project management approach to home health and distribution is vital.

    Mar 3, 2023
  • Digital Health Technologies Gaining Ground In Clinical Trials

    Clinical Research News | Growing interest in the use and utility of digital health technologies (DHTs) was on full display at the recent Summit for Clinical Ops Executives. While outsourcing professionals were learning from Merck’s experience in evaluating and selecting DHT suppliers, digital data specialists were getting a progress update on a study comparing sensor-based symptom measures with traditional clinician-rated assessments in patients with early, untreated Parkinson’s Disease.

    Mar 1, 2023
  • Best-Yet Systemic Biomarker Predictor Of Knee Osteoarthritis Progression

    Clinical Research News | Researchers at Duke University have come up with the new “best-in-class” systemic biomarker predictive of clinically relevant knee osteoarthritis that significantly outperforms the top-rated urine test when it comes to recognizing disease progression. Development of the targeted multiple reaction monitoring proteomic panel has been a 12-year labor of love for the team.

    Feb 28, 2023
  • Patient Registries Now Fueling Regulatory Decision-Making

    Clinical Research News | The challenges and opportunities of working with patient registries, one of the most frequently used real-world data types supporting pharmaceutical drug development, was the subject of a series of use cases presented at the recent Summit for Clinical Ops Executives.

    Feb 23, 2023
  • MD Anderson Deploys Technology for Novel Cancer Therapy Research, Personalis and Moderna Evaluate Investigational Personalized Cancer Vaccine, More

    Clinical Research News | A University of California, Davis research team predicts the female response based on input from readily available male clinical trial participants; a new solution enables researchers to measure whole transcriptomes and paired T-cell receptor sequences—alpha and beta chains—in up to 1 million cells; Insilico Medicine receives Orphan Drug Designation from the FDA for a first-in-class small molecule inhibitor designed to treat idiopathic pulmonary fibrosis; and more.

    Feb 23, 2023